1. A descriptive cost‐analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high‐dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma. (23rd June 2021) Authors: Monteith, Bethany E.; Venner, Christopher P.; Cheung, Matthew C.; Pater, Joe; Shepherd, Lois; Richardson, Harriet; Reece, Donna; Gul, Engin; Lalancette, Marc; Castonguay, Vincent; Kukreti, Vishal; Tiedemann, Rodger; Phua, Chai; Bhella, Sita; Dudebout, Jill; Sherry, Max; Yen, Hope; Chen, Bingshu E... Journal: European journal of haematology Issue: Volume 107:Number 3(2021) Page Start: 333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP294/#883 Elimusertib, an oral ataxia telangiectasia and RAD3-related inhibitor, in advanced gynecologic cancers with DNA damage response defects. (4th December 2022) Authors: Tan, David S; Castonguay, Vincent; Cote, Gregory; Bono, Johann S De; El-Rayes, Bassel; Gabrail, Nashat; Iwasa, Satoru; Joerger, Markus; Jones, Robert; Sawyer, Michael B; Shapiro, Geoffrey I; Tan, Daniel; Merz, Claudia; Uttenreuther, Regina; Jeffers, Michael; Ferraldeschi, Roberta; Sharma, Neelesh... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Estimation of expectedness: Predictive accuracy of standard therapy outcomes in randomized phase 3 studies in epithelial ovarian cancer. Issue 3 (2nd October 2014) Authors: Castonguay, Vincent; Wilson, Michelle K.; Diaz‐Padilla, Ivan; Wang, Lisa; Oza, Amit M. Journal: Cancer Issue: Volume 121:Issue 3(2015) Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Estimation of expectedness: Predictive accuracy of standard therapy outcomes in randomized phase 3 studies in epithelial ovarian cancer. Issue 3 (2nd October 2014) Authors: Castonguay, Vincent; Wilson, Michelle K.; Diaz‐Padilla, Ivan; Wang, Lisa; Oza, Amit M. Journal: Cancer Issue: Volume 121:Issue 3(2015) Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy. Issue 11 (3rd November 2022) Authors: Choueiri, Toni K; Kluger, Harriet; George, Saby; Tykodi, Scott S; Kuzel, Timothy M; Perets, Ruth; Nair, Suresh; Procopio, Giuseppe; Carducci, Michael A; Castonguay, Vincent; Folefac, Edmund; Lee, Chung-Han; Hotte, Sebastien J.; Miller,, Wilson H; Saggi, Shruti Shally; Lee, Chung-Wei; Desilva, Hes... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 11(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 4 (April 2023) Authors: Monk, Bradley J; Tewari, Krishnansu S; Dubot, Coraline; Caceres, M Valeria; Hasegawa, Kosei; Shapira-Frommer, Ronnie; Salman, Pamela; Yañez, Eduardo; Gümüş, Mahmut; Hurtado de Mendoza, Mivael Olivera; Samouëlian, Vanessa; Castonguay, Vincent; Arkhipov, Alexander; Tekin, Cumhur; Li, Kan; Martin Ng... Journal: Lancet oncology Issue: Volume 24:Issue 4(2023) Page Start: 392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer. Issue 1 (January 2022) Authors: Colombo, Nicoletta; Dubot, Coraline; Lorusso, Domenica; Caceres, M. Valeria; Hasegawa, Kosei; Shapira-Frommer, Ronnie; Tewari, Krishnansu S.; Salman, Pamela; Usta, Edwin Hoyos; Yañez, Eduardo; Gümüş, Mahmut; Olivera Hurtado de Mendoza, Mivael; Samouëlian, Vanessa; Castonguay, Vincent; Arkhipov, A... Journal: Obstetrical & gynecological survey Issue: Volume 77:Issue 1(2022) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer. Issue 1 (January 2022) Authors: Colombo, Nicoletta; Dubot, Coraline; Lorusso, Domenica; Caceres, M. Valeria; Hasegawa, Kosei; Shapira-Frommer, Ronnie; Tewari, Krishnansu S.; Salman, Pamela; Usta, Edwin Hoyos; Yañez, Eduardo; Gümüş, Mahmut; Olivera Hurtado de Mendoza, Mivael; Samouëlian, Vanessa; Castonguay, Vincent; Arkhipov, A... Journal: Obstetrical & gynecological survey Issue: Volume 77:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways. (28th January 2023) Authors: Lacombe, Louis; Hovington, Hélène; Brisson, Hervé; Mehdi, Sadia; Beillevaire, Déborah; Émond, Jean-Philippe; Wagner, Antoine; Villeneuve, Lyne; Simonyan, David; Ouellet, Véronique; Barrès, Véronique; Latour, Mathieu; Aprikian, Armen; Bergeron, Alain; Castonguay, Vincent; Couture, Félix; Chevalier... Journal: Cancer letters Issue: Volume 553(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗